tinzaparin
Selected indexed studies
- Tinzaparin. (, 2006) [PMID:30000864]
- Tinzaparin. (Heart Dis, 2002) [PMID:12350245]
- Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review. (Clin Appl Thromb Hemost, 2021) [PMID:33464938]
_Worker-drafted node — pending editorial review._
Connections
tinzaparin is a side effect of
Sources
- Tinzaparin. (2006) pubmed
- Tinzaparin. (2002) pubmed
- Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review. (2021) pubmed
- The Role of Tinzaparin in Oncology. (2018) pubmed
- Tinzaparin-a review of its molecular profile, pharmacology, special properties, and clinical uses. (2022) pubmed
- Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications. (2020) pubmed
- Tinzaparin sodium: a low-molecular-weight heparin. (2002) pubmed
- Tinzaparin sodium: a review of its pharmacology and clinical use in the prophylaxis and treatment of thromboembolic disease. (2004) pubmed
- Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study. (2024) pubmed
- Tinzaparin: considerations for use in clinical practice. (2003) pubmed